Document Detail


Differences in stroke outcome based on sex.
MedLine Citation:
PMID:  20194917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Stroke thrombolysis may have a differential effect by sex. We sought to examine the relationship between sex and outcome after thrombolysis.
METHODS: This is a retrospective cohort study of stroke patients from the Registry of Canadian Stroke Network phase 1 (June 2001-February 2002) and phase 2 (June 2002-December 2002). Variables including demographics, history, clinical data, process measures, and outcome were analyzed. The primary outcomes were the Stroke Impact Scale-16 score (SIS-16) and mortality at 6 months. We compared the outcomes of the thrombolyzed and nonthrombolyzed cohorts and examined the data for a tissue plasminogen activator (tPA)-by-sex interaction on the 2 primary outcomes.
RESULTS: The overall proportion of patients who achieved an excellent outcome (SIS-16 >75) was not different by gender. However, the proportion of patients achieving an excellent outcome in the non-tPA cohort was much greater in males, with an absolute risk difference of 11.8%. A multiplicative treatment by sex interaction was evident (p = 0.054). This interaction was not present for stroke case fatality.
CONCLUSIONS: Women fared poorly compared to men in the placebo groups, but this negative prognostic sex effect was neutralized by thrombolysis.
Authors:
N Shobha; P N Sylaja; M K Kapral; J Fang; M D Hill;
Related Documents :
19259077 - Resolution of tracheal aspiration after the acute phase of stroke-related oropharyngeal...
23504647 - Does obesity affect the outcomes of primary total knee arthroplasty?
24051507 - The difference between weight-bearing and non-weight-bearing alignment in patient-speci...
23493107 - Hemodynamics and early recovery characteristics of desflurane versus sevoflurane in bar...
8823107 - Determinants of prolonged mechanical ventilation after coronary artery bypass grafting.
19190547 - Intravitreal ranibizumab, intravitreal ranibizumab with pdt, and intravitreal triamcino...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurology     Volume:  74     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-02     Completed Date:  2010-04-06     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  767-71     Citation Subset:  AIM; IM    
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, T2N 2T9, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Canada / epidemiology
Cohort Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Registries
Retrospective Studies
Severity of Illness Index
Sex Factors
Stroke / epidemiology*,  mortality,  therapy
Thrombolytic Therapy
Time Factors
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
EC 3.4.21.68/Tissue Plasminogen Activator
Comments/Corrections
Erratum In:
Neurology. 2010 Mar 23;74(12):1008

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.
Next Document:  Glyoxylate rather than ascorbate is an efficient precursor for oxalate biosynthesis in rice.